| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2876638 | The Annals of Thoracic Surgery | 2014 | 7 Pages |
Abstract
Clinical T1-2N0-1 lung cancer with a single-organ metastatic lesion was a good candidate for surgical resection. A 5-year survival rate of about 40% can be expected, which could be comparable with that for stage II non-small cell lung cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Chiaki MD, PhD, Tohru MD, PhD, Yuji MD, PhD, Nobuyuki MD, PhD, Hiroyuki MD, PhD, Hiroyuki MD, PhD, Motoyasu MD, PhD, Takao MD, PhD, Satomi MD, PhD, Jotaro MD, PhD, Masahide MD, PhD, Takashi MD, PhD,